| Purpose | Announcement Date | Right Issue Date | Record Date | Rights Ratio | Premium | Remark |
|---|---|---|---|---|---|---|
| Rights | 6 Mar 2026 | 10 Mar 2026 | 10 Mar 2026 | 1:1 | 0 | 1:1 Rights Issue Of Equity Shares |
| 1:1 Rights Issue Of Equity Shares Jfl Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on March 24, 2026 that the Company has not achieved the minimum subscription requirement of 90% of the issue size, as prescribed under Regulation 86 (2) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, hence in this regards we are under process to give instruction to RTA i.e KFin Technologies Limited for Refund / unblock of amount lying under the ASBA Account who have applied for this Rights issue. (As Per NSE Announcement Dated on: 24/03/2026) | ||||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
